02/17/2021 5:10 AM | Aspire Capital Fund, LLC (Filed by) aTyr Pharma (Subject)
| Form SC 13G
| |
02/16/2021 10:21 AM | Alyeska Investment Group, L.P. (Filed by) aTyr Pharma (Subject)
| Form SC 13G
| |
02/12/2021 12:17 PM | aTyr Pharma (Subject) FEDERATED HERMES, INC. (Filed by)
| Form SC 13G/A
| |
02/09/2021 8:15 PM | aTyr Pharma (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2021 8:12 PM | aTyr Pharma (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2021 3:16 PM | aTyr Pharma (Filer)
| Form 424B5
| |
02/08/2021 7:18 PM | aTyr Pharma (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2021 7:13 PM | aTyr Pharma (Issuer) DENYES NANCY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2021 7:08 PM | aTyr Pharma (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2021 9:15 AM | aTyr Pharma (Subject) FMR LLC (Filed by)
| Form SC 13G/A
| |
|
01/25/2021 7:05 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/22/2021 7:05 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/14/2021 7:05 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2021 8:01 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2021 3:20 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/23/2020 11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
11/13/2020 4:24 PM | aTyr Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/02/2020 4:11 PM | aTyr Pharma (Filer)
| Form 424B3
| |
09/28/2020 11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
09/18/2020 3:26 PM | aTyr Pharma (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
09/14/2020 7:05 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2020 8:47 PM | aTyr Pharma (Issuer) CLARKE JOHN K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2020 8:09 PM | aTyr Pharma (Issuer) CLARKE JOHN K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2020 3:40 PM | aTyr Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2020 3:05 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2020 3:27 PM | aTyr Pharma (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2020 8:00 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2020 7:26 PM | aTyr Pharma (Issuer) DENYES NANCY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2020 7:22 PM | aTyr Pharma (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2020 7:17 PM | aTyr Pharma (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2020 7:13 PM | aTyr Pharma (Issuer) SCHIMMEL PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 3:19 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2020 3:16 PM | aTyr Pharma (Filer)
| Form 424B5
| |
05/12/2020 4:06 PM | aTyr Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2020 4:14 PM | aTyr Pharma (Issuer) SCHIMMEL PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2020 4:08 PM | aTyr Pharma (Issuer) Lucas Svetlana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2020 7:35 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/26/2020 3:16 PM | aTyr Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/18/2020 4:13 PM | aTyr Pharma (Filer)
| Form PRE 14A
| |
02/28/2020 4:16 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/18/2020 1:46 PM | Altium Capital Management LP (Filed by) aTyr Pharma (Subject)
| Form SC 13G
| |
02/12/2020 1:41 PM | aTyr Pharma (Subject) RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G
| |
02/11/2020 12:27 PM | aTyr Pharma (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A
| |
02/11/2020 10:58 AM | aTyr Pharma (Issuer) SCHIMMEL PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 6:37 PM | aTyr Pharma (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 6:34 PM | aTyr Pharma (Issuer) DENYES NANCY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2020 6:30 PM | aTyr Pharma (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2020 4:31 PM | aTyr Pharma (Filer)
| Form 424B4
| |
02/05/2020 11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
02/05/2020 8:53 PM | aTyr Pharma (Filer)
| Form POS EX
| |
02/05/2020 8:48 PM | aTyr Pharma (Filer)
| Form S-1MEF
| |
02/03/2020 7:01 AM | aTyr Pharma (Filer)
| Form S-1/A
| |
01/27/2020 7:03 AM | aTyr Pharma (Filer)
| Form S-1/A
| |
01/17/2020 7:03 AM | aTyr Pharma (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
01/14/2020 4:28 PM | Alta Partners VIII, L.P. (Filed by) aTyr Pharma (Subject)
| Form SC 13G/A
| |
01/06/2020 8:05 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2019 7:10 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2019 3:05 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2019 8:46 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2019 3:44 PM | aTyr Pharma (Subject) Polaris Venture Partners V, L.P. (Filed by)
| Form SC 13D/A
| |
07/10/2019 1:58 PM | aTyr Pharma (Subject) FMR LLC (Filed by)
| Form SC 13G/A
| |
07/02/2019 4:11 PM | aTyr Pharma (Issuer) Lucas Svetlana (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/02/2019 4:09 PM | aTyr Pharma (Issuer) Gross Jane A (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/01/2019 8:00 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2019 3:15 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2019 11:15 PM | aTyr Pharma (Filer)
| Form EFFECT
| |
06/18/2019 4:28 PM | aTyr Pharma (Filer)
| Form S-3/A
| |
06/10/2019 10:51 AM | aTyr Pharma (Subject) FMR LLC (Filed by)
| Form SC 13G/A
| |
05/21/2019 8:56 PM | aTyr Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/21/2019 7:45 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2019 7:43 PM | aTyr Pharma (Filer)
| Form 424B5
| |
05/20/2019 3:38 PM | aTyr Pharma (Issuer) Krueger Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2019 8:00 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2019 3:15 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2019 6:40 PM | aTyr Pharma (Issuer) BLAIR JAMES C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2019 4:35 PM | aTyr Pharma (Issuer) SCHIMMEL PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2019 4:29 PM | aTyr Pharma (Issuer) MENDLEIN JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2019 4:22 PM | aTyr Pharma (Issuer) Hatfield Jeffrey S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2019 4:06 PM | aTyr Pharma (Issuer) Coughlin Timothy P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2019 4:01 PM | aTyr Pharma (Issuer) CLARKE JOHN K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2019 3:11 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2019 1:42 PM | aTyr Pharma (Subject) FEDERATED INVESTORS INC /PA/ (Filed by)
| Form SC 13G
| |
04/16/2019 3:57 PM | aTyr Pharma (Subject) SCHIMMEL PAUL (Filed by)
| Form SC 13D/A
| |
04/16/2019 3:31 PM | aTyr Pharma (Issuer) SCHIMMEL PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2019 7:30 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2019 7:16 AM | aTyr Pharma (Filer)
| Form 424B5
| |
03/28/2019 3:15 PM | aTyr Pharma (Filer)
| Form DEFA14A
| |
03/28/2019 3:12 PM | aTyr Pharma (Filer)
| Form DEFA14A
| |
03/28/2019 3:00 PM | aTyr Pharma (Filer)
| Form DEF 14A
| |
03/26/2019 4:28 PM | aTyr Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/25/2019 3:15 PM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2019 8:00 AM | aTyr Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2019 3:59 PM | aTyr Pharma (Filer)
| Form PRE 14A
| |
02/12/2019 3:30 PM | Alta Partners VIII, L.P. (Filed by) aTyr Pharma (Subject)
| Form SC 13G/A
| |
02/08/2019 7:12 PM | aTyr Pharma (Issuer) Krueger Nancy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2019 7:06 PM | aTyr Pharma (Issuer) Krueger Nancy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/08/2019 6:16 PM | aTyr Pharma (Issuer) Broadfoot Jill Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2019 6:09 PM | aTyr Pharma (Issuer) Shukla Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2019 4:18 PM | aTyr Pharma (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A
| |
12/26/2018 3:15 PM | aTyr Pharma (Issuer) MENDLEIN JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |